Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? – study protocol for a randomized controlled trial [NCT00120978]
<p>Abstract</p> <p>Background</p> <p>Systemic inflammation is associated with various complications in chronic obstructive pulmonary disease including weight loss, cachexia, osteoporosis, cancer and cardiovascular diseases. Inhaled corticosteroids attenuate airway infla...
Main Authors: | Ramesh Warren, Mainra Rajesh R, York Ernest, Wong Eric, FitzGerald Mark, Ford Gordon, Marciniuk Darcy D, Man SF Paul, Sin Don D, Melenka Lyle S, Wilde Eric, Cowie Robert L, Williams Dave, Rousseau Roxanne |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-02-01
|
Series: | BMC Pulmonary Medicine |
Online Access: | http://www.biomedcentral.com/1471-2466/6/3 |
Similar Items
-
Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease
by: Lundblad Lennart K, et al.
Published: (2010-02-01) -
Fluticasone propionate-salmeterol versus inhaled corticosteroids plus montelukast: outcomes study in pediatric patients with asthma
by: Stanford RH, et al.
Published: (2012-12-01) -
Superiority of tiotropium plus olodaterol in comparison with salmeterol plus fluticasone
by: Tamura T, et al.
Published: (2016-11-01) -
New developed spectrophotometric method for simultaneous determination of salmeterol xinafoate and fluticasone propionate in bulk powder and Seritide® diskus inhalation
by: Ahmed Samir, et al.
Published: (2012-12-01) -
Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
by: Barnes, N, et al.
Published: (2006)